Unknown

Dataset Information

0

Reconstitution of TCA cycle involving l-isoleucine dioxygenase for hydroxylation of l-isoleucine in Escherichia coli using CRISPR-Cas9.


ABSTRACT: l-isoleucine dioxygenase (IDO) is an Fe (II)/α-ketoglutarate (α-KG)-dependent dioxygenase that specifically converts l-isoleucine (l-Ile) to (2S, 3R, 4S)-4-hydroxyisoleucine (4-HIL). 4-HIL is an important drug for the treatment and prevention of type 1 and type 2 diabetes but the yields using current methods are low. In this study, the CRISPR-Cas9 gene editing system was used to knockout sucAB and aceAK gene in the TCA cycle pathway of Escherichia coli (E. coli). For single-gene knockout, the whole process took approximately 7 days. However, the manipulation time was reduced by 2 days for each round of gene modification for multigene editing. Using the genome-edited recombinant strain E. coli BL21(DE3) ΔsucABΔaceAK/pET-28a(+)-ido (2Δ-ido), the bioconversion ratio of L-Ile to 4-HIL was enhanced by about 15% compared to E. coli BL21(DE3)/pET-28a(+)-ido [BL21(DE3)-ido] strain. The CRISPR-Cas9 editing strategy has the potential in modifying multiple genes more rapidly and in optimizing strains for industrial production.

SUBMITTER: An J 

PROVIDER: S-EPMC7070131 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10180240 | biostudies-literature
| S-EPMC4538657 | biostudies-other
| S-EPMC3684760 | biostudies-literature
| S-EPMC8654791 | biostudies-literature
| S-EPMC7031464 | biostudies-literature
| S-EPMC10715208 | biostudies-literature
| S-EPMC5462464 | biostudies-literature
| S-EPMC2680622 | biostudies-other
| S-EPMC5979566 | biostudies-literature
| S-EPMC4357945 | biostudies-literature